High variability of albuminuria in nondiabetic population: The Takahata Study

Clinical and Experimental Nephrology

Volumn 13, Issue 5, 2009, Pages 452-459

  Suzuki, Kazuko ^a   Konta, Tsuneo ^a   Takasaki, Satoshi ^a   Ikeda, Ami ^a   Ichikawa, Kazunobu ^a   Sato, Hitoshi ^a   Shibata, Yoko ^a   Watanabe, Tetsu ^a   Kato, Takeo ^a   Kawata, Sumio ^a   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Albuminuria; Body weight; Salt intake

Indexed keywords

ALBUMIN; CREATININE; HEMOGLOBIN;

ADULT; ALBUMINURIA; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CREATININE URINE LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR; SODIUM URINE LEVEL;

ADULT; AGED; ALBUMINURIA; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS;

EID: 70349669501     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-009-0177-3     Document Type: Article

References (23)

1. T Deckert B Feldt-Rasmussen K Borch-Johnsen T Jensen A Kofoed-Enevoldsen 1989 Albuminuria reflects widespread vascular damage. The Steno hypothesis Diabetologia 32 219 226 2668076 10.1007/BF00285287 1:STN:280: DyaL1MzjvFSjtA%3D%3D (Pubitemid 19136363)
2. HH Parving H Lehnert J Bröchner-Mortensen R Gomis S Andersen P Arner 2001 Irbesartan in patients with type 2 diabetes and Microalbuminuria Study Group. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes N Engl J Med 345 870 878 11565519 10.1056/NEJMoa011489 1:CAS:528:DC%2BD3MXntlelsLY%3D (Pubitemid 34940826)
3. AH Brantsma J Atthobari SJ Bakker D de Zeeuw PE de Jong RT Gansevoort 2007 What predicts progression and regression of urinary albumin excretion in the nondiabetic population? J Am Soc Nephrol 18 637 645 17215442 10.1681/ASN.2006070738 1:CAS:528:DC%2BD2sXit12isrc%3D (Pubitemid 46193330)
4. WB Eijkelkamp Z Zhang G Remuzzi HH Parving ME Cooper WF Keane, et al. 2007 Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial J Am Soc Nephrol 18 1540 1546 17409317 10.1681/ASN.2006050445 1:CAS:528:DC%2BD2sXls1Glu7Y%3D (Pubitemid 46717521)
5. JM Pascual E Rodilla A Miralles C Gonzalez J Redon 2006 Determinants of urinary albumin excretion reduction in essential hypertension: a long-term follow-up study J Hypertens 24 2277 2284 17053551 10.1097/01.hjh.0000249707. 36393.02 1:CAS:528:DC%2BD28XhtV2rs7zL (Pubitemid 44611038)
6. AK Bello D de Zeeuw M El Nahas AH Brantsma SJ Bakker PE de Jong, et al. 2007 Impact of weight change on albuminuria in the general population Nephrol Dial Transplant 22 1619 1627 17360767 10.1093/ndt/gfm091 1:CAS:528: DC%2BD2sXot1Sgs7s%3D (Pubitemid 47073760)
7. T Konta Z Hao H Abiko M Ishikawa T Takahashi A Ikeda, et al. 2006 Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study Kidney Int 70 751 756 16807548 10.1038/sj.ki.5001504 1:CAS:528:DC%2BD28XnvVylt7o%3D (Pubitemid 44215351)
8. WHO/IASO/IOTF. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia Pty Ltd.; 2000.
9. AS Levey KU Eckardt Y Tsukamoto A Levin J Coresh J Rossert, et al. 2005 Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO) Kidney Int 67 2089 2100 15882252 10.1111/j.1523-1755.2005.00365.x (Pubitemid 41623371)
10. MF Yuyun AI Adler NJ Wareham 2005 What is the evidence that microalbuminuria is a predictor of cardiovascular disease events? Curr Opin Nephrol Hypertens 14 271 276 15821422 10.1097/01.mnh.0000165895.90748.3b 1:CAS:528:DC%2BD2MXltVKru7w%3D
11. HJ Lambers Heerspink JW Brinkman SJ Bakker RT Gansevoort D de Zeeuw 2006 Update on microalbuminuria as a biomarker in renal and cardiovascular disease Curr Opin Nephrol Hypertens 15 631 636 17053479 10.1097/01.mnh.0000247496.54882. 3f (Pubitemid 44607436)
12. PE de Jong GC Curhan 2006 Screening, monitoring, and treatment of albuminuria: public health perspectives J Am Soc Nephrol 17 2120 2126 16825331 10.1681/ASN.2006010097 (Pubitemid 44141901)
13. HC Gerstein JF Mann Q Yi B Zinman SF Dinneen B Hoogwerf, et al. 2001 Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals JAMA 286 421 426 11466120 10.1001/jama.286.4.421 1:CAS:528:DC%2BD3MXlvFKksL0%3D
14. HL Hillege V Fidler GF Diercks WH van Gilst D de Zeeuw DJ van Veldhuisen, et al. 2002 Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population Circulation 106 1777 1782 12356629 10.1161/01.CIR.0000031732.78052.81 1:CAS:528:DC%2BD38Xnt1GnsLg%3D
15. PE de Jong RT Gansevoort SJ Bakker 2007 Macroalbuminuria and microalbuminuria: do both predict renal and cardiovascular events with similar strength? J Nephrol 20 375 380 17879201
16. E Imai M Horio K Nitta K Yamagata K Iseki S Hara, et al. 2007 Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease Clin Exp Nephrol 11 41 50 17384997 10.1007/s10157-006-0453-4 (Pubitemid 46474965)
17. T Kawasaki K Itoh K Uezono H Sasaki 1993 A simple method for estimating 24 h urinary sodium and potassium excretion from second morning voiding urine specimen in adults Clin Exp Pharmacol Physiol 20 7 14 8432042 10.1111/j.1440-1681.1993.tb01496.x 1:CAS:528:DyaK3sXpslGisg%3D%3D
18. K Wachtell H Ibsen MH Olsen K Borch-Johnsen LH Lindholm CE Mogensen, et al. 2003 Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study Ann Intern Med 139 901 906 14644892
19. JC Verhave HL Hillege JG Burgerhof WM Janssen RT Gansevoort GJ Navis, et al. 2004 Sodium intake affects urinary albumin excretion especially in overweight subjects J Intern Med 256 324 330 15367175 10.1111/j.1365-2796.2004. 01390.x 1:CAS:528:DC%2BD2cXptlKhtL8%3D (Pubitemid 39304344)
20. JE Heeg PE de Jong GK van der Hem D de Zeeuw 1989 Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril Kidney Int 36 272 279 2550696 10.1038/ki.1989.190 1:STN:280:DyaL1MzotlWgtg%3D%3D
21. S Dittrich K Kurschat PE Lange 2001 Abnormal rheology in cyanotic congenital heart disease-a factor in non-immune nephropathy Scand J Urol Nephrol 35 411 415 11771869 10.1080/003655901753224486 1:STN:280: DC%2BD38%2FksVChug%3D%3D (Pubitemid 33095951)
22. SB Solerte M Fioravanti N Pezza M Locatelli N Schifino N Cerutti, et al. 1997 Hyperviscosity and microproteinuria in central obesity: relevance to cardiovascular risk Int J Obes Relat Metab Disord 21 417 423 9192223 10.1038/sj.ijo.0800421 1:CAS:528:DyaK2sXksVWqsrg%3D
23. AH Brantsma SJ Bakker D de Zeeuw PE de Jong RT Gansevoort PREVEND Study Group 2008 Extended prognostic value of urinary albumin excretion for cardiovascular events J Am Soc Nephrol 19 1785 1791 18525003 10.1681/ASN.2007101065